Filing Details

Accession Number:
0001209191-21-067893
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-03 17:12:10
Reporting Period:
2021-11-01
Accepted Time:
2021-12-03 17:12:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1087294 Cumberland Pharmaceuticals Inc CPIX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1490829 James Jones 2525 West End Avenue
Suite 950
Nashville TN 37203
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-01 42 $2.67 18,102 No 4 P Direct
Common Stock Acquisiton 2021-11-02 42 $2.63 18,144 No 4 P Direct
Common Stock Acquisiton 2021-11-03 42 $2.71 18,186 No 4 P Direct
Common Stock Acquisiton 2021-11-04 42 $2.73 18,228 No 4 P Direct
Common Stock Acquisiton 2021-11-05 42 $2.71 18,270 No 4 P Direct
Common Stock Acquisiton 2021-11-08 42 $2.95 18,312 No 4 P Direct
Common Stock Acquisiton 2021-11-09 42 $3.21 18,354 No 4 P Direct
Common Stock Acquisiton 2021-11-10 42 $2.94 18,396 No 4 P Direct
Common Stock Acquisiton 2021-11-11 42 $2.83 18,438 No 4 P Direct
Common Stock Acquisiton 2021-11-12 42 $2.67 18,480 No 4 P Direct
Common Stock Acquisiton 2021-11-15 42 $2.71 18,522 No 4 P Direct
Common Stock Acquisiton 2021-11-16 42 $2.66 18,564 No 4 P Direct
Common Stock Acquisiton 2021-11-17 42 $2.58 18,606 No 4 P Direct
Common Stock Acquisiton 2021-11-18 42 $2.58 18,648 No 4 P Direct
Common Stock Acquisiton 2021-11-19 42 $2.55 18,690 No 4 P Direct
Common Stock Acquisiton 2021-11-22 42 $2.35 18,732 No 4 P Direct
Common Stock Acquisiton 2021-11-23 42 $2.29 18,774 No 4 P Direct
Common Stock Acquisiton 2021-11-24 42 $2.31 18,816 No 4 P Direct
Common Stock Acquisiton 2021-11-26 42 $2.26 18,858 No 4 P Direct
Common Stock Acquisiton 2021-11-29 42 $2.23 18,900 No 4 P Direct
Common Stock Acquisiton 2021-11-30 42 $4.61 18,942 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.